Annual Shareholders Equity
$7.38 M
+$40.66 M+122.16%
December 31, 2023
Summary
- As of February 7, 2025, CRVO annual stockholders equity is $7.38 million, with the most recent change of +$40.66 million (+122.16%) on December 31, 2023.
- During the last 3 years, CRVO annual shareholders equity has fallen by -$17.44 million (-70.27%).
- CRVO annual shareholders equity is now -80.67% below its all-time high of $38.17 million, reached on December 1, 2014.
Performance
CRVO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$45.64 M
-$4.34 M-8.68%
September 30, 2024
Summary
- As of February 7, 2025, CRVO quarterly stockholders equity is $45.64 million, with the most recent change of -$4.34 million (-8.68%) on September 30, 2024.
- Over the past year, CRVO quarterly shareholders equity has increased by +$40.30 million (+755.21%).
- CRVO quarterly shareholders equity is now -14.93% below its all-time high of $53.65 million, reached on March 1, 2021.
Performance
CRVO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CRVO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +122.2% | +755.2% |
| 3 y3 years | -70.3% | +755.2% |
| 5 y5 years | -52.8% | +755.2% |
CRVO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.9% | +122.2% | -8.7% | +237.1% |
| 5 y | 5-year | -78.9% | +122.2% | -14.9% | +237.1% |
| alltime | all time | -80.7% | +122.2% | -14.9% | +237.1% |
CervoMed Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $45.64 M(-8.7%) |
| Jun 2024 | - | $49.98 M(+836.5%) |
| Mar 2024 | - | $5.34 M(-27.7%) |
| Dec 2023 | $7.38 M(-122.2%) | $7.38 M(-23.0%) |
| Sep 2023 | - | $9.57 M(-32.7%) |
| Jun 2023 | - | $14.23 M(-12.6%) |
| Mar 2023 | - | $16.28 M(-148.9%) |
| Dec 2022 | -$33.29 M(-195.3%) | - |
| Dec 2022 | - | -$33.29 M(-238.4%) |
| Sep 2022 | - | $24.05 M(-9.8%) |
| Jun 2022 | - | $26.67 M(-12.9%) |
| Mar 2022 | - | $30.62 M(-12.3%) |
| Dec 2021 | $34.91 M(+40.7%) | $34.91 M(-8.4%) |
| Sep 2021 | - | $38.13 M(-24.0%) |
| Jun 2021 | - | $50.17 M(-6.5%) |
| Mar 2021 | - | $53.65 M(+116.2%) |
| Dec 2020 | $24.81 M(+23.2%) | $24.81 M(-13.6%) |
| Sep 2020 | - | $28.72 M(-12.6%) |
| Jun 2020 | - | $32.88 M(+83.7%) |
| Mar 2020 | - | $17.90 M(-11.1%) |
| Dec 2019 | $20.13 M(+29.0%) | $20.13 M(+48.9%) |
| Sep 2019 | - | $13.52 M(-16.4%) |
| Jun 2019 | - | $16.18 M(+24.9%) |
| Mar 2019 | - | $12.96 M(-17.0%) |
| Dec 2018 | $15.61 M(-26.5%) | $15.61 M(-25.3%) |
| Sep 2018 | - | $20.91 M(-23.4%) |
| Jun 2018 | - | $27.30 M(-8.1%) |
| Mar 2018 | - | $29.72 M(+40.0%) |
| Dec 2017 | $21.23 M(+131.1%) | $21.23 M(+234.0%) |
| Sep 2017 | - | $6.36 M(+444.4%) |
| Jun 2017 | - | $1.17 M(-106.1%) |
| Mar 2017 | - | -$19.12 M(-308.2%) |
| Dec 2016 | $9.18 M(<-9900.0%) | $9.18 M(-20.0%) |
| Sep 2016 | - | $11.49 M(-18.1%) |
| Jun 2016 | - | $14.03 M(-15.4%) |
| Mar 2016 | - | $16.58 M(<-9900.0%) |
| Dec 2015 | -$41.60 K | -$41.60 K(-100.2%) |
| Sep 2015 | - | $19.07 M(-40.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $31.81 M(-9.8%) |
| Mar 2015 | - | $35.25 M(-7.6%) |
| Dec 2014 | $38.17 M(+490.9%) | $38.17 M(-10.8%) |
| Sep 2014 | - | $42.80 M(-5.5%) |
| Jun 2014 | - | $45.30 M(+270.8%) |
| Mar 2014 | - | $12.21 M(+89.1%) |
| Dec 2013 | $6.46 M(-135.1%) | $6.46 M(-202.7%) |
| Sep 2013 | - | -$6.29 M(-26.4%) |
| Jun 2013 | - | -$8.54 M(-56.7%) |
| Mar 2013 | - | -$19.71 M(+7.2%) |
| Dec 2012 | -$18.39 M(+14.7%) | -$18.39 M(+204.9%) |
| Sep 2012 | - | -$6.03 M(+18.9%) |
| Jun 2012 | - | -$5.07 M(+137.4%) |
| Mar 2012 | - | -$2.14 M(-86.7%) |
| Dec 2011 | -$16.03 M(<-9900.0%) | -$16.03 M(-417.4%) |
| Sep 2011 | - | $5.05 M(-42.2%) |
| Jun 2011 | - | $8.75 M(-1309.8%) |
| Mar 2011 | - | -$722.90 K(-3678.7%) |
| Dec 2010 | $20.20 K(-95.9%) | $20.20 K(-98.7%) |
| Sep 2010 | - | $1.59 M(-3.6%) |
| Jun 2010 | - | $1.65 M(+18.5%) |
| Mar 2010 | - | $1.39 M(+181.7%) |
| Dec 2009 | $493.60 K(+12.4%) | $493.60 K(+1009.2%) |
| Sep 2009 | - | $44.50 K(-90.7%) |
| Jun 2009 | - | $479.60 K(+75.0%) |
| Mar 2009 | - | $274.00 K(-37.6%) |
| Dec 2008 | $439.00 K(-148.5%) | $439.00 K(-146.7%) |
| Sep 2008 | - | -$940.40 K(+24.1%) |
| Jun 2008 | - | -$757.80 K(+64.8%) |
| Mar 2008 | - | -$459.90 K(-49.2%) |
| Dec 2007 | -$905.90 K(+533.5%) | -$905.90 K(+344.7%) |
| Sep 2007 | - | -$203.70 K(+6.6%) |
| Jun 2007 | - | -$191.00 K(+28.9%) |
| Mar 2007 | - | -$148.20 K(+3.6%) |
| Dec 2006 | -$143.00 K(+50.7%) | -$143.00 K |
| Dec 2005 | -$94.90 K(-103.4%) | - |
| Dec 1999 | $2.77 M(-49.6%) | - |
| Dec 1998 | $5.50 M | - |
FAQ
- What is CervoMed annual stockholders equity?
- What is the all time high annual shareholders equity for CervoMed?
- What is CervoMed annual shareholders equity year-on-year change?
- What is CervoMed quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CervoMed?
- What is CervoMed quarterly shareholders equity year-on-year change?
What is CervoMed annual stockholders equity?
The current annual shareholders equity of CRVO is $7.38 M
What is the all time high annual shareholders equity for CervoMed?
CervoMed all-time high annual stockholders equity is $38.17 M
What is CervoMed annual shareholders equity year-on-year change?
Over the past year, CRVO annual stockholders equity has changed by +$40.66 M (+122.16%)
What is CervoMed quarterly stockholders equity?
The current quarterly shareholders equity of CRVO is $45.64 M
What is the all time high quarterly shareholders equity for CervoMed?
CervoMed all-time high quarterly stockholders equity is $53.65 M
What is CervoMed quarterly shareholders equity year-on-year change?
Over the past year, CRVO quarterly stockholders equity has changed by +$40.30 M (+755.21%)